Evidence map›Paper›PMID 17406683›Full record

ArticlePloS one2007

Evolutionary diversification of SPANX-N sperm protein gene structure and expression.

Natalay Kouprina, Vladimir N Noskov, Adam Pavlicek, N Keith Collins, Pamela D Schoppee Bortz, Chris Ottolenghi, Dmitri Loukinov, Paul Goldsmith, John I Risinger, Jung-Hyun Kim and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. PeerJ · 2020
    Article
  10. TAR Cloning: Perspectives for Functional Genomics, Biomedicine, and Biotechnology.Molecular therapy. Methods & clinical development · 2019
    Review
  11. BORIS: a key regulator of cancer stemness.Cancer cell international · 2018
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Natalay KouprinaLaboratory of Molecular Pharmacology, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, United States of America. kouprinn@mail.nih.gov
Vladimir N Noskov
Adam Pavlicek
N Keith Collins
Pamela D Schoppee Bortz
Chris Ottolenghi
Dmitri Loukinov
Paul Goldsmith
John I Risinger
Jung-Hyun Kim
V Anne Westbrook
Gregory Solomon
Hanna Sounders
John C Herr
Jerzy Jurka
Victor Lobanenkov
David Schlessinger
Vladimir Larionov
National Institutes of Health · USNational Cancer Institute · USGenetic Information Research Institute · USNational Institute of Allergy and Infectious Diseases · USUniversity of Virginia Health System · USNational Institute of Environmental Health Sciences · USNational Institute on Aging · USUniversity of Virginia · US

Funding

Study of hereditary prostate cancer and human artificial chromosomesZIABC010413 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LARIONOV, VLADIMIR · 2009 to 2025
$31.5M
Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targetsZIAAI000860 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LOBANENKOV, VICTOR · 2009 to 2025
$15.4M
Genes Associated With Ovarian Development and Premature Ovarian Failure - testZIAAG000647 · NIA · NATIONAL INSTITUTE ON AGING · PI SCHLESSINGER, DAVID · 2009 to 2017
$6.2M
Study of hereditary prostate cancer and human artificial chromosomesZ01BC010413 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LARIONOV, VLADIMIR · 2000 to 2008
$2.4M
Transcriptional Regulation Of Ctcf And Boris ExpressionZ01AI000860 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI LOBANENKOV, VICTOR · 2000 to 2008
$1.5M
Translocations/genes in Premature Ovarian FailureZ01AG000647 · NIA · NATIONAL INSTITUTE ON AGING · PI SCHLESSINGER, DAVID · 1998 to 2008
$1.2M
6 · The paper itself

Abstract

The sperm protein associated with nucleus in the X chromosome (SPANX) genes cluster at Xq27 in two subfamilies, SPANX-A/D and SPANX-N. SPANX-A/D is specific for hominoids and is fairly well characterized. The SPANX-N gave rise to SPANX-A/D in the hominoid lineage approximately 7 MYA. Given the proposed role of SPANX genes in spermatogenesis, we have extended studies to SPANX-N gene evolution, variation, regulation of expression, and intra-sperm localization. By immunofluorescence analysis, SPANX-N proteins are localized in post-meiotic spermatids exclusively, like SPANX-A/D. But in contrast to SPANX-A/D, SPANX-N are found in all ejaculated spermatozoa rather than only in a subpopulation, are localized in the acrosome rather than in the nuclear envelope, and are expressed at a low level in several nongametogenic adult tissues as well as many cancers. Presence of a binding site for CTCF and its testis-specific paralogue BORIS in the SPANX promoters suggests, by analogy to MAGE-A1 and NY-ESO-1, that their activation in spermatogenesis is mediated by the programmed replacement of CTCF by BORIS. Based on the relative density of CpG, the more extended expression of SPANX-N compared to SPANX-A/D in nongametogenic tissues is likely attributed to differences in promoter methylation. Our findings suggest that the recent duplication of SPANX genes in hominoids was accompanied by different localization of SPANX-N proteins in post-meiotic sperm and additional expression in several nongonadal tissues. This suggests a corresponding functional diversification of SPANX gene families in hominoids. SPANX proteins thus provide unique targets to investigate their roles in the function of spermatozoa, selected malignancies, and for SPANX-N, in other tissues as well.

Indexed as

Evolution, MolecularAmino Acid SequenceAnimalsAntibody SpecificityCell Line, TumorChromosomes, Human, XElectrophoretic Mobility Shift AssayFluorescent Antibody TechniqueFluorescent Antibody Technique, IndirectHumansMaleMolecular Sequence DataNuclear ProteinsPromoter Regions, GeneticRecombinant ProteinsReverse Transcriptase Polymerase Chain ReactionNuclear ProteinsRecombinant ProteinsSPANXA1 protein, human

Identifiers

PMID17406683
PMCPMC1831492
OpenAlexW2088075604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.